April 2012 Drug Information Update - Pharmacy Benefits ...

24 (Display case UPC# 30300450749230); Tylenol RRG/PM 24s, Motrin CAP 24s CU (Display
case UPC# 30300450754821); and TYl ES/PM/RRG/MOT IB/PM 24s DIST PK (Display case
UPC# 30300450755873). Recall # D-1217-2012
CODE
1) Lot ADA069, Exp. 01/12; ALA168, Exp. 04/12; ALA244, Exp. 08/12; AMA286, Exp. 09/12;
APA001, Exp. 09/12; ASA001, Exp. 10/12;
2) Lot ACA310, Exp. 12/11; ACA460, Exp. 01/12; ADA407, Exp. 02/12; AEA262, Exp. 03/12;
AFA226, Exp. 04/12; AJA170, Exp. 03/12; ALA037, Exp. 07/12; ALA163, Exp. 04/12;
AMA012, Exp. 08/12; AMA331, Exp. 05/12; AMA342, Exp. 08/12; APA035, Exp. 09/12;
ASA082, Exp. 09/12; ASA123, Exp. 10/12; ASA285, Exp. 09/12; BDA238, Exp. 11/12;
BDA260, Exp. 01/13; BDA383, Exp. 01/13; BEA065, Exp. 01/13; BEA148, Exp. 02/13; Exp.
03/13; BEA269, Exp. 03/13; BEA277, Exp. 03/13; BFA064, Exp.04/13; BFA144, Exp. 04/13;
BFA244, Exp. 05/13; BHA078, Exp. 05/13; BHA147, Exp. 04/13; BHA167, Exp. 04/13;
BHA198, Exp. 05/13; BJA164, Exp. 05/13; BJA221, Exp/. 06/13; BMA144, Exp. 08/13;
BMA215, Exp. 08/13; BMA271, Exp. 08/13; BSA022, Exp. 07/13; BSA056, Exp. 10/13;
CBA063, Exp. 12/13; CBA107, Exp. 12/13; CCA028, Exp. 01/14; CDA003, Exp. 02/14;
CFA065, Exp. 01/14; CFA100, Exp. 01/14; CHA012, Exp. 01/14; CHA044, Exp. 01/14;
CHA066, Exp. 01/14; CHA080, Exp. 05/14; CMA028, Exp. 05/14; CMA035, Exp. 05/14;
CMA057, Exp. 05/14; CMA102, Exp. 06/14; CMA108, Exp. 05/14; ACA761, Exp. 01/12;
ALA265, Exp. 08/12
RECALLING FIRM/MANUFACTURER
Recalling Firm: McNeil Consumer Healthcare, Div Of McNeil-ppc, Inc, Fort, Washington, PA,
by letter and WEB posting on December 21, 2011.
Manufacturer: Dr. Reddy's Laboratories Louisiana LLC, Shreveport, LA. Firm initiated recall is
ongoing.
REASON
Failed USP Dissolution Test Requirements: McNeil is recalling these products because testing of
product sample showed that some caplets may not dissolve as quickly as intended when nearing
their expiration date.
PRODUCT (Class III)
Bupropion Hydrochloride Extended-Release Tablets (XL), 150mg tablets,150mg, packaged in
10-count UD tablets (NDC #68084-251-11), 10 x 10-count tablets per box (NDC 68084-251-
01) Rx only, Recall # D-1248-2012
CODE
AHP Lot 110564, Exp. Date 03/31/2012; AHP Lot 103077, Exp. Date 03/31/2012; AHP Lot
103499, Exp. Date 06/30/2012 & AHP Lot 110450, Exp. Date 03/31/2012
RECALLING FIRM/MANUFACTURER
Recalling Firm: American Health Packaging, Columbus, OH, by letters on January 18, 2912.
Manufacturers: Actavis South Atlantic LLC. Sunrise, FL;
CMIC CMO USA Corp., Cranbury, NJ. Firm initiated recall is ongoing.
REASON
Failed USP Dissolution Requirements: American Health Packaging was notified by their
supplier that the product is being recalled due to possible out-of-specification dissolution results
for 8-hours stability testing point.
31